|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
208,280,000 |
Market
Cap: |
1.95(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$5.09 - $15.86 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,693,990 |
Total Buy Value |
$0 |
$0 |
$0 |
$12,897,789 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
27 |
Total Shares Sold |
567,946 |
1,097,598 |
2,193,115 |
3,020,700 |
Total Sell Value |
$5,420,056 |
$10,572,222 |
$21,602,157 |
$28,825,014 |
Total People Sold |
4 |
7 |
8 |
8 |
Total Sell Transactions |
23 |
46 |
97 |
149 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Larson Tina Marriott |
President and COO |
|
2022-12-29 |
4 |
AS |
$7.70 |
$61,566 |
D/D |
(8,000) |
203,654 |
|
-28% |
|
Larson Tina Marriott |
President and COO |
|
2022-12-29 |
4 |
OE |
$1.06 |
$8,480 |
D/D |
8,000 |
211,654 |
|
- |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2022-12-28 |
4 |
B |
$7.18 |
$511,898 |
I/I |
71,299 |
11,609,266 |
1.5 |
-20% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2022-12-27 |
4 |
B |
$7.24 |
$1,054,404 |
I/I |
145,652 |
11,537,967 |
1.5 |
-22% |
|
Borgeson Blake |
Director |
|
2022-12-27 |
4 |
AS |
$7.25 |
$64,373 |
D/D |
(8,885) |
7,628,272 |
|
-22% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2022-12-23 |
4 |
B |
$7.52 |
$754,421 |
I/I |
100,378 |
11,392,315 |
1.5 |
-31% |
|
Virani Shafique |
Chief Business Officer |
|
2022-12-15 |
4 |
AS |
$8.85 |
$88,525 |
D/D |
(10,000) |
78,160 |
|
-42% |
|
Virani Shafique |
Chief Business Officer |
|
2022-12-15 |
4 |
OE |
$2.22 |
$11,100 |
D/D |
5,000 |
88,160 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-12-14 |
4/A |
GD |
$0.00 |
$0 |
D/D |
3,000 |
582,805 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,000 |
585,805 |
|
- |
|
Borgeson Blake |
Director |
|
2022-12-13 |
4 |
AS |
$8.96 |
$79,598 |
D/D |
(8,885) |
7,637,157 |
|
-42% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-12-01 |
4 |
AS |
$9.26 |
$23,187 |
I/I |
(2,500) |
0 |
|
-30% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-12-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500 |
1,000 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-12-01 |
4 |
AS |
$8.77 |
$335,760 |
D/D |
(37,210) |
582,805 |
|
-30% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
601,305 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-12-01 |
4 |
OE |
$2.48 |
$77,500 |
D/D |
31,250 |
601,515 |
|
- |
|
Borgeson Blake |
Director |
|
2022-11-29 |
4 |
AS |
$8.75 |
$77,786 |
D/D |
(8,885) |
7,646,042 |
|
-26% |
|
Larson Tina Marriott |
President and COO |
|
2022-11-17 |
4 |
AS |
$10.96 |
$175,402 |
D/D |
(16,000) |
203,654 |
|
-39% |
|
Larson Tina Marriott |
President and COO |
|
2022-11-17 |
4 |
OE |
$1.06 |
$16,960 |
D/D |
16,000 |
219,654 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-11-16 |
4/A |
GD |
$0.00 |
$0 |
D/D |
3,000 |
582,805 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-11-16 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,000 |
585,805 |
|
- |
|
Borgeson Blake |
Director |
|
2022-11-16 |
4 |
AS |
$11.12 |
$197,610 |
D/D |
(17,770) |
7,654,927 |
|
-43% |
|
Larson Tina Marriott |
President and COO |
|
2022-11-15 |
4 |
D |
$11.86 |
$17,233 |
D/D |
(1,453) |
203,654 |
|
- |
|
Virani Shafique |
Chief Business Officer |
|
2022-11-15 |
4 |
AS |
$11.92 |
$123,123 |
D/D |
(10,000) |
83,160 |
|
-43% |
|
Virani Shafique |
Chief Business Officer |
|
2022-11-15 |
4 |
OE |
$2.22 |
$11,100 |
D/D |
5,000 |
93,160 |
|
- |
|
628 Records found
|
|
Page 14 of 26 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|